Christopher Leamon

Insider Reports History

Entity
Individual
Location
C/O Fusion Pharmaceuticals Inc., 2 International Place Suite 2310, Boston, MA
Signature
/s/ Maria Stahl as Attorney-in-Fact for Christopher Leamon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Leamon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fusion Pharmaceuticals Inc. Chief Scientific Officer Common Stock 0 $0 $2.03 Jun 4, 2024 Direct
Fusion Pharmaceuticals Inc. Chief Scientific Officer Restricted Stock Units 0 $0 $2.03 Jun 4, 2024 Direct
Fusion Pharmaceuticals Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 Jun 4, 2024 Direct

Insider Reports Filed by Christopher Leamon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2024 5 $0 4 Jun 4, 2024 Chief Scientific Officer
FUSN Fusion Pharmaceuticals Inc. Aug 31, 2023 3 $0 4 Jan 5, 2024 Chief Scientific Officer
FUSN Fusion Pharmaceuticals Inc. Jan 5, 2023 1 $0 4 Jan 9, 2023 Chief Scientific Officer
FUSN Fusion Pharmaceuticals Inc. Nov 1, 2021 1 $0 4 Nov 2, 2021 Chief Scientific Officer
FUSN Fusion Pharmaceuticals Inc. Nov 1, 2021 0 $0 3 Nov 2, 2021 Chief Scientific Officer